Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-10-07 | Mr. Williams received a B.A. in accountancy from Southern Illinois University and completed the director education and certification program at the University of California, Los Angeles Anderson School of Business. |
| 2022-08-31 | Donald Williams ... In accordance with the merger transaction with Seneca Biopharma, Inc. ("Seneca") effected April 27, 2021, the board of directors of Seneca (the "Seneca Board") appointed Thomas Hallam, Ph.D., James R. Neal, Stephanie Diaz, Robert J. Trenschel, D.O. and Don Williams to the Board. |
| 2022-08-31 | Donald Williams |
| 2023-04-21 | Mr. Williams received a B.A. in accountancy from Southern Illinois University and completed the director education and certification program at the University of California, Los Angeles Anderson School of Business. |
| 2024-02-06 | Donald Williams(7) Includes (i) 30,000 shares of common stock and (ii) 1,258 shares of common stock underlying stock options. |
| 2024-05-22 | Mr. Williams received a B.A. in accountancy from Southern Illinois University and completed the director education and certification program at the University of California, Los Angeles Anderson School of Business. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25